ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Short Term Renal Allograft Outcomes Following Treatment of Early Subclinical Borderline Changes on Surveillance Biopsies.

C. James, K. Woodside, J. Park, A. Naik, E. Farkash, R. Sung, M. Samaniego, Y. Huang.

University of Michigan, Ann Arbor, MI

Meeting: 2017 American Transplant Congress

Abstract number: B139

Keywords: Kidney, Kidney transplantation, Protocol biopsy, Rejection

Session Information

Session Name: Poster Session B: Kidney Complications II

Session Type: Poster Session

Date: Sunday, April 30, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

There is no consensus on treating subclinical borderline changes on surveillance biopsy in kidney transplant (KT) recipients. We examined whether treatment with pulsed corticosteroids led to differential allograft outcomes.

Methods: This is a single-center retrospective review of 169 consecutive adult KT-alone recipients with biopsies done per indication and per protocol at 3, 6, and 12 months. Recipients with graft failure, rejection requiring treatment, BK viremia (>1000 copies/mL), or donor specific antibody prior to or at time of case identification were excluded. 29 patients with subclinical borderline changes on either 3 or 6-month surveillance biopsy were selected and grouped by treatment (3 daily 250 mg IV methylprednisolone or oral equivalent) vs no treatment per clinician discretion. Outcomes examined included subsequent histology on indication or 1-yr protocol biopsy, new BK viremia by 2 yrs, and estimated GFR by MDRD equation at 1 and 2 yrs post-KT.

Results: There were no statistically significant differences in demographics, immunological risk profile, or immunosuppression between the two groups, although there was a numerically higher proportion of African American, high PRA patients in the treated group (Table 1). There was one loss to follow-up in the treated group, but no death or graft loss was observed in either group by 2 yrs post-KT. There were no significant differences in subsequent histology, BK viremia, or 1 and 2-yr eGFR between the two groups (Table 2).Conclusion: There was no difference in outcomes between patients treated for subclinical borderline changes on 3 or 6-month surveillance biopsy and those not treated. Treatment also did not increase risk of BK viremia. Future prospective randomized studies could be conducted on a larger cohort.

CITATION INFORMATION: James C, Woodside K, Park J, Naik A, Farkash E, Sung R, Samaniego M, Huang Y. Short Term Renal Allograft Outcomes Following Treatment of Early Subclinical Borderline Changes on Surveillance Biopsies. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

James C, Woodside K, Park J, Naik A, Farkash E, Sung R, Samaniego M, Huang Y. Short Term Renal Allograft Outcomes Following Treatment of Early Subclinical Borderline Changes on Surveillance Biopsies. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/short-term-renal-allograft-outcomes-following-treatment-of-early-subclinical-borderline-changes-on-surveillance-biopsies/. Accessed May 28, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences